http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013500276-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-24 |
| filingDate | 2010-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2013500276-A |
| titleOfInvention | Agomelatine and drug composition thereof |
| abstract | The present invention provides agomelatine crystals, which are drugs for treating depression, and drug compositions thereof. The agomelatine crystal has an X-ray powder diffraction spectrum of 12.84, 13.84, 16.14, 18.56, 19.12 using Cu-K α- ray and represented by 2θ (degrees). There are characteristic diffraction peaks at 20.86, 21.20, 23.84, and in the infrared absorption spectrum, about 3234, 3060, 2940, 1638, 1511, 1436, 1249, 1215, 1184, 1032, 908, There are characteristic absorption peaks at 828, 755, and 588 cm −1 , and the DSC endothermic conversion temperature is 97.6 ° C. The agomelatin crystals further provide use in the manufacture of a medicament for treating depression as an active ingredient. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016536351-A |
| priorityDate | 2009-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.